Sun, Oct 26, 2014, 1:33 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ARYx Therapeutics, Inc. Message Board

  • dah174174 dah174174 May 26, 2009 5:16 PM Flag

    2M sell a non-event

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • agree that this is a non-event.

      Orbimed is getting out of a number of positions right now, of which ARYX is only one.

      Also, Orbimed got these shares on the cheap, and made a nice profit on their sale.

      Most importantly, given their "insider" status (they owned more than 10%) the SEC will be all over Orbimed in a nanosecond if bad news comes out in the next few months (info on upcoming catalysts like partnership(s) and clinical trial data is without question material nonpublic information). For guys as rich as Orbimed, this is clearly not worth going to jail over, particularly in this anti-investor political climate.

      But the speculators can continue to speculate and shorts are already trying to make hay out of this non-sense.

      one thing the shorts will almost certainly ignore is how sophisticated and well-informed the buyers of Orbimed shares are and how much due diligence was involved in making the purchase decision.

    • You are wrong. Orbimed is a 5 billion dollar hedge fund specializing in this space and they sold just under 2/3 of their position for $4.

      There is no way they would do this if they had confidence that the new technology being developed by Aryx will work.

      Yes they still have 1.3m shares - for now. So what.

      PS - I have no position, I just am following this stock because I find the potential of what they have to be compelling.

 
ARYX
0.00450.0000(0.00%)Oct 23 1:58 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.